Health & Medicine Research

Health & Medicine Research

The university-wide Center for Healthcare Innovation (CHI) supports faculty and student-initiated multidisciplinary research that addresses gaps and issues related to advancing biomedical technology and healthcare delivery and serves as a focal point for integration of external strategic partnerships.

Major areas of research include tissue engineering of cancer biopsies for drug development and therapy selection, biomaterials that control infection of implanted prosthetic and medical devices, mobile healthcare and telemedicine apps, and data analytics and modeling of healthcare delivery systems. Below is a selection of research conducted by the CCBBME department and CHI.

Progeria Protein Discovery
New characteristics linked to premature aging disease.

Dr. Joseph Glavy at Stevens Institute of Technology studies the smallest and most basic elements of life. His team has uncovered a disease-related protein outside of its known range and published the results in the August 2010 issue of Cell Cycle.

Can an Ant Colony Help Trauma Patients?
Swarm intelligence, as seen in an ant colony, allows biomedical engineers to more accurately predict tissue growth in nerve grafts.

As technology advances towards complex tissue engineering methods, scientists are hitting a ceiling on how accurate computer models can simulate tissue grafts grown to repair a patient's damaged tissues. Dr. Xiaojun Yu, Associate Professor of Biomedical Engineering, and Dr. Yan Meng, Assistant Professor of Computer Engineering, are collaborating to break through the existing technology barrier and develop smarter nerve tissue grafts. To evolve techniques in tissue engineering, the Stevens scientists propose to apply knowledge from the field of swarm intelligence to improve their accuracy.

Accelerating Pharmaceuticals into the Market
Computational chemistry allows scientists to test drugs virtually before running expensive trials.

Dr. Yong Zhang, Associate Professor of Chemistry at Stevens Institute of Technology, is developing a method for computational analysis of drugs and living proteins that allows researchers to test-run their experimental medicines before conducting laboratory trials. Using the principles of chemistry and quantum mechanics, together with lessons learned from lab experiments, he has created simulations that accurately model drug interactions at the atomic level.

Investigating Ant Pheromones
New insight into how certain parasites locate host ants.

Dr. Attygalle, an expert in both natural products chemistry and mass spectrometry, has recently been awarded a National Science Foundation (NSF) grant to investigate ant pheromones. Professor Attygalle intends to find how certain parasitic flies eavesdrop on ants' chemical signals to locate their preferred hosts.


Read how Stevens is innovating:



Dr. Peter Tolias
Interim Department Director
(201) 216-8253
[email protected]

Dr. Patricia Muisener
CCB Program Director
(201) 216-3715
[email protected]

Dr. Philip Leopold
Biology Program Director
(201) 216-5528
[email protected]

Dr. Vikki Hazelwood
BME Program Director
(201) 216-5051
[email protected]

Dr. Marissa Gray
Associate Director for Graduate Programs
(201) 216-3662
[email protected]